Find Etofibrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 31637-97-5, Etofibrate [inn], 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl pyridine-3-carboxylate, Ethofibrate, 23tf67g79m, Etofibrate (inn)
Molecular Formula
C18H18ClNO5
Molecular Weight
363.8  g/mol
InChI Key
XXRVYAFBUDSLJX-UHFFFAOYSA-N
FDA UNII
23TF67G79M

Etofibrate
Etofibrate is an orally-available combination of clofibrate and niacin linked together by an ester bond. In the body clofibrate and niacin separate, acting as a controlled-release formulation.
1 2D Structure

Etofibrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl pyridine-3-carboxylate
2.1.2 InChI
InChI=1S/C18H18ClNO5/c1-18(2,25-15-7-5-14(19)6-8-15)17(22)24-11-10-23-16(21)13-4-3-9-20-12-13/h3-9,12H,10-11H2,1-2H3
2.1.3 InChI Key
XXRVYAFBUDSLJX-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(C(=O)OCCOC(=O)C1=CN=CC=C1)OC2=CC=C(C=C2)Cl
2.2 Other Identifiers
2.2.1 UNII
23TF67G79M
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Etofibrate Hydrochloride

2. Lipo-merz

3. Tricerol

2.3.2 Depositor-Supplied Synonyms

1. 31637-97-5

2. Etofibrate [inn]

3. 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl Pyridine-3-carboxylate

4. Ethofibrate

5. 23tf67g79m

6. Etofibrate (inn)

7. Lipo-merz

8. 2-hydroxyethyl Nicotinate 2-(p-chlorophenoxy)-2-methylpropionate (ester)

9. Etofibrato

10. Etofibratum

11. 2-(2-(4-chlorophenoxy)-2-methylpropanoyloxy)ethyl Nicotinate

12. Etofibratum [inn-latin]

13. Etofibrato [inn-spanish]

14. Einecs 250-743-1

15. Unii-23tf67g79m

16. Etofibrate [mi]

17. Etofibrate [mart.]

18. Schembl3122

19. 3-pyridinecarboxylic Acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]ethyl Ester

20. Etofibrate [who-dd]

21. Mls006010106

22. Etofibrate, Analytical Standard

23. Chembl358150

24. Dtxsid80185521

25. Chebi:135535

26. Hms3652n04

27. 2-((2-(4-chlorophenoxy)-2-methylpropanoyl)oxy)ethyl Nicotinate

28. Bcp07572

29. Hy-a0127

30. Zinc2019929

31. Mfcd00865727

32. 2-(p-chlorophenoxy)-2-methylpropionic Acid 2-(nicotinoyloxy)ethyl Ester

33. Akos025311314

34. Ccg-268206

35. Db08983

36. 121ge005

37. Ac-23121

38. As-16847

39. Smr002529563

40. Cs-0017444

41. E1359

42. Ft-0660287

43. S4264

44. Sw219681-1

45. D07187

46. T72280

47. 637e975

48. Q-201101

49. Q4116990

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 363.8 g/mol
Molecular Formula C18H18ClNO5
XLogP33.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count9
Exact Mass363.0873504 g/mol
Monoisotopic Mass363.0873504 g/mol
Topological Polar Surface Area74.7 Ų
Heavy Atom Count25
Formal Charge0
Complexity449
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Hypolipidemic Agents

Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)


Anticholesteremic Agents

Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)


4.2 ATC Code

C - Cardiovascular system

C10 - Lipid modifying agents

C10A - Lipid modifying agents, plain

C10AB - Fibrates

C10AB09 - Etofibrate


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty